0.05Open0.05Pre Close0 Volume811 Open Interest6.00Strike Price0.00Turnover153.01%IV26.57%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1248Delta0.2359Gamma95.60Leverage Ratio-0.0168Theta0.0001Rho11.93Eff Leverage0.0012Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet